• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACS LYSING SOLUTION; RED CELL LYSING REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACS LYSING SOLUTION; RED CELL LYSING REAGENT Back to Search Results
Model Number 349202
Device Problem Device Markings/Labelling Problem (2911)
Patient Problems No Patient Involvement (2645); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/17/2020
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that incorrect label information was found on the bd facs lysing solution.There was no report of patient impact.The following information was provided by the initial reporter: labeling issue (b)(4) facslysing, cfda class i registration and chinese product manual shows as formaldehyde less than 10%.However, current bottle outside label was outdated and mistaken, showing formaldehyde less than 15%.It seems the labels were not updated after cfda class i registration and product manual updated in early 2019.And customers are worried about the quality and functionality.
 
Event Description
It was reported that incorrect label information was found on the bd facs lysing solution.There was no report of patient impact.The following information was provided by the initial reporter: labeling issue.349202 facslysing, cfda class i registration and chinese product manual shows as formaldehyde less than 10%.However, current bottle outside label was outdated and mistaken, showing formaldehyde less than 15%.It seems the labels were not updated after cfda class i registration and product manual updated in early 2019.And customers are worried about the quality and functionality.
 
Manufacturer Narrative
H.6.Investigation: problem statement: customer reported complaint on (b)(6) 2020.Scope.The scope of issue is limited to part 349202.Manufacturing defect trend: there are no other qns related to the reported issue for the date range between 17dec2019 and 17dec2020.Complaint trend: there are no complaints besides this complaint related to the reported issue from date 17dec2019 to 17dec2020.Batch history record (bhr) review: bhr for 349202-0031304 was reviewed and found to be labeled appropriately.This report refers to labeling content.Retain sample evaluation / testing: the retain sample part and lot was visually inspected and found to be labeled properly.Returned sample evaluation: the sample was not requested to be returned because the reported issue is an issue of labeling content.Investigation result / analysis: the investigation was performed and based on the review of complaint trend, defect trend, bhr, root cause and risk analysis, the reported complaint was unconfirmed.There have been no changes to the composition of facs lysing solution m/n 349202.Risk analysis: there have been no non-conformities in 349202-0031304 or changes to the composition of facs lysing solution m/n 349202.These is no risk represented by the revision of the label; both revisions of the labeled formaldehyde concentration are correct.Root cause analysis: based on the investigation result, root cause was not determined.Investigation conclusion: based on the investigation result, complaint was not confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD FACS LYSING SOLUTION
Type of Device
RED CELL LYSING REAGENT
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
MDR Report Key11167753
MDR Text Key239351543
Report Number2916837-2021-00021
Device Sequence Number1
Product Code GGK
UDI-Device Identifier00382903492022
UDI-Public00382903492022
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 06/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/13/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date02/28/2022
Device Model Number349202
Device Catalogue Number349202
Device Lot Number0031304
Was Device Available for Evaluation? No
Date Manufacturer Received06/21/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-